
Metabolic & Weight
AOD-9604
GH Fragment 176–191
Price
$54

Hormone & Growth Research
GHRH + GHRP Blend
A paired growth-hormone-releasing-hormone analog and secretagogue blend, 5 mg of each sequence per vial, studied in endocrine-signaling research.
A paired preparation of CJC-1295 (No-DAC), a GHRH analog, and ipamorelin, a selective growth-hormone secretagogue. Supplying both sequences in one vial supports endocrine-signaling research that examines GHRH- and GHRP-pathway interaction.
Research context
Certificate in queue
This lot is with our third-party laboratory. Its certificate will be published here and on the COA lookup as soon as testing completes.
How every batch is tested$98
Dispatched within 24 hours, Monday to Friday, in discreet, unmarked packaging. Free shipping over $200 — $102 away.
COA match guarantee — if the vial you receive does not match the certificate published for its batch, we replace or refund it. Unopened vials in original packaging can be returned within 14 days of delivery.
A batch that misses specification is not listed and is not shipped. We publish every result we commission, including the ones that send a batch back.
Chromatogram and mass-spectrometry data for this compound are available on request.
For Research Use Only — Not for Human Consumption.
Specifications
Every lot in this catalog clears the same sequence. The dates below belong to batch GLP3-10-2026-01 — an example of a released lot. Certificates for other products are added as testing completes.
Lyophilized to specification and sealed under controlled conditions, one lot at a time.
Lot GLP3-10-2026-01
RP-HPLC with UV detection at 220 nm — the peptide-bond absorbance, so every residue in the sequence contributes to the signal. Release specification ≥ 98.0%.
Result 99.4%
LC-MS (ESI) measures the molecular mass of the eluting species against the theoretical mass of the intended sequence. A lot can be pure and still be the wrong peptide; running both methods closes that gap.
Confirmed
Purity, identity, appearance, peptide content, water, acetate and endotoxins all within specification. Released for sale.
Tested 2026-07-28
It is not listed and it is not shipped. We publish every result we commission, including the ones that send a batch back. A batch earns a product page only after identity and purity have both passed.
Chromatographic purity and peptide content answer different questions. Purity is the share of peptide-related material that is the target sequence. Peptide content is how much of the vial's mass is peptide at all, the remainder being acetate counterion and residual water — a normal lyophilized acetate salt, not a discrepancy.
Analysis is performed by JanoShield Analytical, an independent laboratory with no commercial interest in the result.
For Research Use Only — Not for Human Consumption.
A paired preparation of CJC-1295 (No-DAC), a GHRH analog, and ipamorelin, a selective growth-hormone secretagogue. Supplying both sequences in one vial supports endocrine-signaling research that examines GHRH- and GHRP-pathway interaction.
Every lot is assayed by third-party hplc and mass spectrometry, per batch: RP-HPLC at 220 nm establishes chromatographic purity against a 99% release specification, and LC-MS confirms molecular identity against the reference mass. The batch currently shipping is RV-CJI-2451, and its full certificate — including methods, specifications, measured results, and the testing laboratory — is published at https://rovapeptides.com/coas/RV-CJI-2451.
Lyophilized powder, sealed vial. Store lyophilized at -20 °C, protected from light and moisture. Refrigerate after reconstitution. Reconstitute with bacteriostatic water in a controlled laboratory setting; swirl gently rather than shaking to preserve peptide structure.
CJC-1295 No-DAC / Ipamorelin Blend is supplied in 5 mg / 5 mg. Each presentation is filled from a tested lot and ships with its own batch number, so the certificate you retrieve always corresponds to the vial in your hand.
No. CJC-1295 No-DAC / Ipamorelin Blend is supplied strictly for laboratory and in-vitro research use. It is not intended for human or veterinary consumption, diagnostic use, or therapeutic use, and RovaPeptides provides no dosing, protocol, or usage guidance.
Related Research Products